121-135 of 143
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Jonathan Barratt, MD, PhD
Annette Bruchfeld, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CEUnderstanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Jonathan Barratt, MD, PhD
Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
CME/CESeparating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
- advertisement
David Jayne, MD
Annette Bruchfeld, MD, PhD
Jürgen Floege, MD
Jonathan Barratt, MD, PhD
David Jayne, MD
Case Management Strategies for Patients with ADPKD – Part 2
CME/CECase Management Strategies for Patients with ADPKD – Part 2
Frederic Rahbari-Oskoui, MD, MSc
Case Management Strategies for Patients with ADPKD – Part 1
CME/CECase Management Strategies for Patients with ADPKD – Part 1
Fouad T. Chebib, MD
Pranav S. Garimella, MD
Kristen Nowak, PhD
- advertisement
Imaging in the Diagnosis and Management of ADPKD
CME/CEImaging in the Diagnosis and Management of ADPKD
Theodora A. Potretzke, MD
Fouad T. Chebib, MD
Neera Dahl, MD, PhD
Craig E. Gordon, MD
Frederic Rahbari-Oskoui, MD, MSc
Melanie Betz, MS, RD, CSR, CSG
